文献速递支持与姑息治疗

估算欧洲青少年和年轻成人癌症患者的治愈比例和其他原因死亡风险

Estimating cure and risk of death from other causes of adolescent and young adult cancer patients in Europe.
PubMed 文献 · Eur J Cancer · 2025-04-19

该研究应用传统和新型混合治愈模型,基于EUROCARE-6中1998至2002年诊断、随访至2014年的欧洲青少年和年轻成人(15-39岁)常见癌症病例,估计非癌原因死亡的相对风险(RR)和治愈比例(CF)。研究发现白血病、淋巴瘤、中枢神经系统肿瘤、黑色素瘤、睾丸生殖细胞癌、乳腺癌和宫颈癌的RR>1,且年轻患者RR通常更高并随年龄下降;青少年患者CF高于30-39岁患者。

要点

  • 白血病、淋巴瘤、中枢神经系统肿瘤、黑色素瘤、睾丸生殖细胞癌、乳腺癌和宫颈癌患者非癌死亡风险升高。
  • 年轻患者非癌死亡相对风险通常更高,并随年龄增长而下降。
  • 青少年患者治愈比例高于30-39岁患者,尤其在急性淋巴细胞白血病、男性中枢神经系统肿瘤和女性结直肠癌中。

核心结论

  • 需要进一步研究以理解青少年和年轻成人患者非癌死亡相对风险升高的原因,并调查合并症和治疗副作用。
  • 准确估计癌症死亡率和治愈比例对于资源分配、定制随访护理和改善患者生活质量至关重要。

研究设计与样本

  • 应用传统和新型混合治愈模型(包含多种参数生存函数)分析最常见的青少年和年轻成人癌症。
  • 数据来自EUROCARE-6,纳入1998年至2002年诊断、随访至2014年的病例。
  • 采用定性和定量标准选择最优模型,按癌症类型、年龄组和性别估计治愈比例和相对风险。

主要发现

  • 白血病、慢性髓性白血病、淋巴瘤、中枢神经系统肿瘤和皮肤黑色素瘤在男女两性中均发现相对风险>1。
  • 睾丸生殖细胞癌、乳腺癌和宫颈癌也发现相对风险>1。
  • 相对风险通常在年轻患者中更高,并随年龄增长而下降。
  • 急性髓性白血病、结直肠癌、男女骨肉瘤以及女性软组织肉瘤、急性淋巴细胞白血病和卵巢生殖细胞癌未见额外风险迹象。
  • 青少年患者治愈比例高于30-39岁患者,尤其在急性淋巴细胞白血病、男性中枢神经系统肿瘤和女性结直肠癌中。

局限性

  • 需要进一步研究以理解青少年和年轻成人患者相对风险升高的原因,并调查合并症和治疗副作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Adolescents and young adults (AYAs), aged 15-39, face unique challenges as cancer survivors, including long-term health issues treatment. This study applies a novel approach to estimate the relative risk (RR) of mortality from non-cancer causes in AYA cancer patients compared to the general population and the cure fraction (CF) for AYA patients. METHODS: Conventional and new mixture cure models with various parametric survival functions were applied to the most common AYA cancers. EUROCARE-6 cases diagnosed between 1998 and 2002, with follow-up to 2014, were selected. Qualitative and quantitative criteria were used to select the optimal model. CFs and RRs were estimated by cancer type, age group, and sex. FINDINGS: RRs> 1 were found in both sexes for leukaemia, chronic myeloid leukaemia, lymphoma, central nervous system (CNS) tumours, and skin melanoma, and for testicular germ cell, breast and cervix cancers, with RR generally higher in younger patients and decreasing with age. For acute myeloid leukaemia, colorectal cancer, bone sarcoma for both sexes and soft tissue sarcoma, acute lymphoblastic leukaemia (ALL), and ovary germ cell in females, there was no indication for extra risk. Higher CFs were found in adolescents compared to older AYAs (30-39 years), especially for ALL, CNS tumours in males, and colorectal cancer in females. CONCLUSION: Further studies are needed to understand why RRs are elevated in AYA patients, to investigate comorbidities and side effects of treatment. Accurate estimation of cancer mortality and CF is vital for resource allocation, tailored follow-up care, and imporving patient quality of life.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Botta L, Capocaccia R, Vener C, et al. Estimating cure and risk of death from other causes of adolescent and young adult cancer patients in Europe. Eur J Cancer. 2025. PMID: 40319677. doi:10.1016/j.ejca.2025.115443

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。